相关实验视频
Updated: Jul 26, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
分析COVID-19疫苗对帕金森病症状的影响
Revati Sabat1, Orrin L Dayton2, Amit Agarwal3
1Eastside High School, Gainesville, FL, United States.
Frontiers in immunology
|June 21, 2023
概括
COVID-19疫苗可能会暂时轻微恶化帕金森病 (PD) 症状. 这项研究发现疫苗副作用,犹和PD患者的症状恶化之间存在相关性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病.
- 由于COVID-19的流行,人们对PD的研究兴趣增加了.
- COVID-19疫苗对PD患者的影响仍未得到充分研究.
研究的目的:
- 为了研究COVID-19疫苗对帕金森病症状的影响.
- 为了解决PD患者由于未知的疫苗效应而对疫苗的犹.
主要方法:
- 对50岁以上接受COVID-19疫苗的帕金森病患者进行的调查.
- 疫苗接种前后评估PD症状严重程度.
- 分析了患者对疫苗接种后症状恶化的反应.
主要成果:
- 在34名符合条件的受访者中,41%的人在接种疫苗后报告了PD症状的恶化 (p=0.0001).
- 症状恶化通常是轻微的和短暂的 (几天).
结论:
- 有证据表明,在COVID-19疫苗接种后,PD症状的恶化具有统计学意义,尽管通常是轻微的.
- 与疫苗犹和一般副作用相关的恶化.
- 潜在的机制包括压力,焦虑和模仿轻微感染的炎症反应.
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
Negative and Cognitive Symptoms of Schizophrenia
100
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
100

